Encompass Health (EHC) Competitors

$86.53
+0.16 (+0.19%)
(As of 05/10/2024 ET)

EHC vs. SEM, VKTX, CHE, LEGN, HSIC, PEN, ROIV, BIO.B, BIO, and RGEN

Should you be buying Encompass Health stock or one of its competitors? The main competitors of Encompass Health include Select Medical (SEM), Viking Therapeutics (VKTX), Chemed (CHE), Legend Biotech (LEGN), Henry Schein (HSIC), Penumbra (PEN), Roivant Sciences (ROIV), Bio-Rad Laboratories (BIO.B), Bio-Rad Laboratories (BIO), and Repligen (RGEN). These companies are all part of the "medical" sector.

Encompass Health vs.

Select Medical (NYSE:SEM) and Encompass Health (NYSE:EHC) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, community ranking, valuation and profitability.

Encompass Health received 159 more outperform votes than Select Medical when rated by MarketBeat users. Likewise, 71.83% of users gave Encompass Health an outperform vote while only 57.85% of users gave Select Medical an outperform vote.

CompanyUnderperformOutperform
Select MedicalOutperform Votes
328
57.85%
Underperform Votes
239
42.15%
Encompass HealthOutperform Votes
487
71.83%
Underperform Votes
191
28.17%

In the previous week, Encompass Health had 8 more articles in the media than Select Medical. MarketBeat recorded 21 mentions for Encompass Health and 13 mentions for Select Medical. Encompass Health's average media sentiment score of 0.79 beat Select Medical's score of 0.71 indicating that Select Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Select Medical
5 Very Positive mention(s)
4 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Encompass Health
6 Very Positive mention(s)
5 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Select Medical pays an annual dividend of $0.50 per share and has a dividend yield of 1.5%. Encompass Health pays an annual dividend of $0.60 per share and has a dividend yield of 0.7%. Select Medical pays out 23.8% of its earnings in the form of a dividend. Encompass Health pays out 16.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Select Medical presently has a consensus target price of $34.25, suggesting a potential upside of 1.96%. Encompass Health has a consensus target price of $90.29, suggesting a potential upside of 4.34%. Given Select Medical's stronger consensus rating and higher probable upside, analysts plainly believe Encompass Health is more favorable than Select Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Select Medical
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Encompass Health
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.13

Select Medical has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. Comparatively, Encompass Health has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500.

89.5% of Select Medical shares are owned by institutional investors. Comparatively, 97.3% of Encompass Health shares are owned by institutional investors. 19.1% of Select Medical shares are owned by insiders. Comparatively, 2.1% of Encompass Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Encompass Health has a net margin of 7.60% compared to Encompass Health's net margin of 3.97%. Encompass Health's return on equity of 18.11% beat Select Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Select Medical3.97% 18.11% 3.64%
Encompass Health 7.60%18.01%6.55%

Encompass Health has lower revenue, but higher earnings than Select Medical. Select Medical is trading at a lower price-to-earnings ratio than Encompass Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Select Medical$6.66B0.66$243.49M$2.1016.00
Encompass Health$4.80B1.81$352M$3.7023.39

Summary

Encompass Health beats Select Medical on 15 of the 21 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EHC vs. The Competition

MetricEncompass HealthHospitals IndustryMedical SectorNYSE Exchange
Market Cap$8.70B$4.57B$5.09B$17.82B
Dividend Yield0.69%1.10%37.43%3.47%
P/E Ratio23.3913.13105.6321.07
Price / Sales1.810.942,426.2310.11
Price / Cash13.279.2147.3318.23
Price / Book3.692.395.225.64
Net Income$352M$178.36M$106.12M$967.12M
7 Day Performance3.99%-0.34%-0.90%1.48%
1 Month Performance5.98%4.15%-3.04%0.93%
1 Year Performance39.84%6.18%4.20%112.99%

Encompass Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SEM
Select Medical
4.8586 of 5 stars
$32.74
+2.0%
$34.80
+6.3%
+15.4%$4.26B$6.66B15.5954,600
VKTX
Viking Therapeutics
4.5101 of 5 stars
$79.61
+1.8%
$112.25
+41.0%
+224.5%$8.78BN/A-85.6028
CHE
Chemed
4.9728 of 5 stars
$580.70
+1.7%
$681.00
+17.3%
+4.3%$8.79B$2.26B31.2515,087Short Interest ↓
Positive News
LEGN
Legend Biotech
2.462 of 5 stars
$45.99
+1.6%
$82.64
+79.7%
-38.4%$8.37B$285.14M-31.071,800Upcoming Earnings
Analyst Forecast
Short Interest ↑
HSIC
Henry Schein
4.4956 of 5 stars
$71.20
+3.9%
$81.09
+13.9%
-3.8%$9.15B$12.34B22.6025,000Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
PEN
Penumbra
4.8354 of 5 stars
$210.00
-0.8%
$304.45
+45.0%
-33.7%$8.14B$1.06B90.914,200Earnings Report
Analyst Forecast
ROIV
Roivant Sciences
3.4415 of 5 stars
$11.38
-1.9%
$16.90
+48.5%
+20.6%$9.17B$123.24M2.19904Positive News
BIO.B
Bio-Rad Laboratories
0 of 5 stars
$279.91
flat
N/A-25.1%$7.98B$2.67B-13.037,900
BIO
Bio-Rad Laboratories
4.7125 of 5 stars
$279.91
-0.7%
$468.00
+67.2%
-22.9%$7.98B$2.67B-13.038,030Earnings Report
Analyst Forecast
Short Interest ↑
RGEN
Repligen
4.2077 of 5 stars
$167.72
-0.2%
$197.75
+17.9%
+7.7%$9.37B$638.76M670.911,783

Related Companies and Tools

This page (NYSE:EHC) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners